Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Robins Harlan S sold 106,160 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Jun 15 to Jun 16, 2026 · Filed Jun 17, 2026
From Jun 15 to Jun 16, 2026, Robins Harlan S (Chief Scientific Officer) sold 106,160 Adaptive Biotechnologies Corporation shares at an average US$17.41 for US$1.85M under a trading plan, leaving 1,405,898 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 106,160 shares
- Price
- US$17.41 average (US$17.37 to US$18.01)
- Value
- US$1.85M
- Holding after
- 1,405,898 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Sale | 100,000 | US$17.37 | 1,412,058 | Direct |
| Jun 16, 2026 | Common Stock | Sale | 6,160 | US$18.01 | 1,405,898 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Robins Harlan S
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Robins Harlan S · Jul 23, 2026
- Form 4 · Robins Harlan S · Jul 7, 2026
- Form 4 · Robins Harlan S · Apr 10, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026